CARIS LIFE SCIENCES, INC. (CAI)
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6
NeoVolta Announces Timing of Third Quarter Fiscal 2026 Earnings Release and Conference Call
Gloo Completes Acquisition of EnterpriseMarketdesk (EMD) Bringing AI-enabled Workday Services and Expertise to the Gloo Platform
DeFi Development Corp. Launches $200 Million At-The-Market Facility (ATM) to Buy More SOL
Barfresh to Present at the LD Micro Invitational XVI
Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference